LAKEESHIA WESTRY: Open Payments
NPI 1922701341 · VESTAVIA HILLS, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,011 in 42 payments from 14 companies in 2025. Trend: 2023 $885 · 2024 $2,300 · 2025 $1,011
Food & beverage: $1,011
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $277 |
| GlaxoSmithKline, LLC. | 11 | $193 |
| Genentech USA, Inc. | 4 | $91 |
| Fresenius USA Marketing, Inc. | 4 | $76 |
| GENZYME CORPORATION | 2 | $59 |
| Novartis Pharmaceuticals Corporation | 2 | $56 |
| Amgen Inc. | 3 | $55 |
| Lilly USA, LLC | 2 | $47 |
| Octapharma USA, Inc. | 2 | $43 |
| CSL Behring | 1 | $33 |
Products named: AIRSUPRA, NUCALA, Xolair, DUPIXENT, TEZSPIRE, VELPHORO, EBGLYSS, TRELEGY ELLIPTA.
Industry payments across AL — which companies pay providers there.
